Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

The FDA doesn’t appear to be buying the two year compromise on user fees that the medical device industry is floating in lieu of a full reauthorization of the fees med tech companies pay to the ...

The reauthorization of FDA’s prescription drug, generics, biosimilar and medical device programs was included in the fiscal 2023 appropriations act, and they are set to expire on Sept. 30, 2027.

To offset this budget cut, the Trump Administration would increase user fees — the amount drug and devicemakers must pay for the agency to review their products — by $1.3 billion, reports STAT ...

According to the new study, in 2022, user fees made up 66 percent of the $2.1 billion budget for regulating drugs and all of the FDA’s $680 million tobacco budget.

The research firm Avalere Health issued a report that found the FDA has received $7.67 billion in user fees ...

The FDA has explained that user fees facilitate “timely availability of innovative FDA-regulated products without compromising the agency’s commitment to scientific integrity, public health ...

The Food and Drug Administration (FDA) collects user fees from drug and medical device companies to fund its work ensuring the safety of these products. Creating a similar program that collects ...

For that work, the FDA charges user fees to companies bringing those items to market to cover the cost of the FDA regulation. According to the FDA’s summary of its 2025 budget, ...

Kennedy is not the only critic of user fees. Former FDA Commissioner Robert Califf, who served under both Barack Obama’s and Joe Biden’s administrations, has previously said he would have ...

WASHINGTON — Health and Human Services Secretary Robert F. Kennedy Jr. and his allies rallied around removing industry influence from the Food and Drug Administration as part of their quest ...